COHANCE LIFESCIENCES
Back to Income Statement
|
COHANCE LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,198 Cr | ₹1,051 Cr | ₹1,340 Cr | ₹1,320 Cr | ₹1,010 Cr |
What is the latest Revenue of COHANCE LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,198 Cr |
| Mar2024 | ₹1,051 Cr |
| Mar2023 | ₹1,340 Cr |
| Mar2022 | ₹1,320 Cr |
| Mar2021 | ₹1,010 Cr |
How is Revenue of COHANCE LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,198 Cr | 13.91 | |
| Mar2024 | ₹1,051 Cr | -21.56 | |
| Mar2023 | ₹1,340 Cr | 1.52 | |
| Mar2022 | ₹1,320 Cr | 30.75 | |
| Mar2021 | ₹1,010 Cr | - | |
Compare Revenue of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,937.7 Cr | -2% | 2.4% | -55.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -2% |
2.4% |
-55.9% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses